DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Oncology Pulse

Stay on top of updates and innovations in the oncology landscape and how it impacts your decisions

How Mylan Used Partnering Deals To Become A Key Player In Biosimilars

View more

Decision Resources Group Announces Oncology Clinical Trial Monitor

View more

The Hepatocellular Carcinoma Market

View more
Ask us your question

How Can Pharma Find Success in the Evolving Immune Checkpoint Inhibitor Pipeline?

View more
Ask us your question

Oncology Clinical Trial Design - Impact of the Latest Industry Guidelines for Pharma

View more

Checkpoint Inhibitor Playbook: 8 Steps to Finding Future Success

View more

DRG Oncology: Your Decisions Made Easier and Faster at Every Point of the Lifecycle

View more

Opdivo + Yervoy’s FDA Win for Colorectal Cancer – What Pharma Needs to Know

View more

PARP Inhibitor Cheat Sheet for Oncology Strategists

View more